MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma

Immunotherapy is a novel approach and has been used in various diseases, especially in cancers. Recently, immunotherapy has gradually been used to treat advanced clear cell renal cell carcinoma (ccRCC) or metastatic ccRCC. However, the efficacy of immunotherapy is not satisfying due to the influence...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Tianbo, Gao, Su, Liu, Jingchong, Huang, Yu, Chen, Ke, Zhang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974879/
https://www.ncbi.nlm.nih.gov/pubmed/33758602
http://dx.doi.org/10.7150/jca.48664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974879/
https://www.ncbi.nlm.nih.gov/pubmed/33758602
http://dx.doi.org/10.7150/jca.48664

Ejemplares similares